Rasool G, Khan W, Khan A, Riaz M, Abbas M, Rehman A
Int J Immunopathol Pharmacol. 2024; 38:3946320241310307.
PMID: 39716038
PMC: 11672396.
DOI: 10.1177/03946320241310307.
Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A
Cell Commun Signal. 2024; 22(1):542.
PMID: 39538298
PMC: 11558984.
DOI: 10.1186/s12964-024-01925-y.
Karolak I, Hrynkiewicz R, Niedzwiedzka-Rystwej P, Lechowicz K, Sienko J, Szylinska A
Int J Mol Sci. 2023; 24(18).
PMID: 37762549
PMC: 10532011.
DOI: 10.3390/ijms241814247.
Zhou X, Tan F, Zhang S, Zhang T
Curr Comput Aided Drug Des. 2023; 20(6):888-910.
PMID: 37559532
DOI: 10.2174/1573409920666230808120504.
Zheng Z, Peng F, Zhou Y
Chin Med J Pulm Crit Care Med. 2023; 1(2):77-83.
PMID: 37388822
PMC: 9988550.
DOI: 10.1016/j.pccm.2022.12.002.
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis.
Cirjaliu R, Deacu M, Gherghisan I, Marghescu A, Enciu M, Baltatescu G
Biomedicines. 2023; 11(6).
PMID: 37371834
PMC: 10296314.
DOI: 10.3390/biomedicines11061739.
Clinical and radiological outcomes of longCOVID: Is the post-COVID fibrosis common?.
Sarioglu N, Aksu G, Coban H, Bulbul E, Demirpolat G, Arslan A
Tuberk Toraks. 2023; 71(1):48-57.
PMID: 36912409
PMC: 10795271.
DOI: 10.5578/tt.20239907.
Lung fibrosis: Post-COVID-19 complications and evidences.
Hirawat R, Jain N, Saifi M, Rachamalla M, Godugu C
Int Immunopharmacol. 2023; 116:109418.
PMID: 36736220
PMC: 9633631.
DOI: 10.1016/j.intimp.2022.109418.
CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis.
Wu J, Chen L, Qin C, Huo F, Liang X, Yang X
Signal Transduct Target Ther. 2022; 7(1):382.
PMID: 36424379
PMC: 9691700.
DOI: 10.1038/s41392-022-01230-5.
Lung function and radiological findings 1 year after COVID-19: a prospective follow-up.
Tarraso J, Safont B, Carbonell-Asins J, Fernandez-Fabrellas E, Sancho-Chust J, Naval E
Respir Res. 2022; 23(1):242.
PMID: 36096801
PMC: 9466319.
DOI: 10.1186/s12931-022-02166-8.
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
Al-Kuraishy H, El-Saber Batiha G, Faidah H, Al-Gareeb A, Saad H, Simal-Gandara J
Inflammopharmacology. 2022; 30(6):2017-2026.
PMID: 36044102
PMC: 9430017.
DOI: 10.1007/s10787-022-01027-6.
NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration.
Baindara P, Sarker M, Earhart A, Mandal S, Schrum A
Front Cell Infect Microbiol. 2022; 12:928704.
PMID: 35992174
PMC: 9386183.
DOI: 10.3389/fcimb.2022.928704.
Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome.
Jutant E, Meyrignac O, Beurnier A, Jais X, Pham T, Morin L
ERJ Open Res. 2022; 8(2).
PMID: 35445129
PMC: 8685862.
DOI: 10.1183/23120541.00479-2021.
[Radiological management and follow-up of post-COVID-19 patients].
Alarcon-Rodriguez J, Fernandez-Velilla M, Urena-Vacas A, Martin-Pinacho J, Rigual-Bobillo J, Jaureguizar-Oriol A
Radiologia. 2022; 63(3):258-269.
PMID: 35370314
PMC: 7914006.
DOI: 10.1016/j.rx.2021.02.003.
Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.
Salvi S, Ghorpade D, Dhoori S, Dhar R, Dumra H, Chhajed P
Lung India. 2022; 39(2):177-186.
PMID: 35259802
PMC: 9053913.
DOI: 10.4103/lungindia.lungindia_659_21.
Pseudo-honeycombing in a patient with coronavirus disease 2019 pneumonia.
Hochhegger B, Zanetti G, Marchiori E
Rev Soc Bras Med Trop. 2022; 55:e0656.
PMID: 35239919
PMC: 8909432.
DOI: 10.1590/0037-8682-0656-2021.
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis-A Randomized Placebo Controlled Clinical Trial.
Kotfis K, Karolak I, Lechowicz K, Zegan-Baranska M, Pikulska A, Niedzwiedzka-Rystwej P
Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215312
PMC: 8874492.
DOI: 10.3390/ph15020200.
COVID-19-related end stage lung disease: two distinct phenotypes.
Kostopanagiotou K, Schuurmans M, Inci I, Hage R
Ann Med. 2022; 54(1):588-590.
PMID: 35168461
PMC: 8856017.
DOI: 10.1080/07853890.2022.2039954.
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra I, Mittermaier M
Cell. 2021; 184(26):6243-6261.e27.
PMID: 34914922
PMC: 8626230.
DOI: 10.1016/j.cell.2021.11.033.
Lung Fibrosis after COVID-19: Treatment Prospects.
Bazdyrev E, Rusina P, Panova M, Novikov F, Grishagin I, Nebolsin V
Pharmaceuticals (Basel). 2021; 14(8).
PMID: 34451904
PMC: 8398080.
DOI: 10.3390/ph14080807.
